Connection

Mitzi Nagarkatti to Endocannabinoids

This is a "connection" page, showing publications Mitzi Nagarkatti has written about Endocannabinoids.
Connection Strength

2.765
  1. Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis. Cells. 2021 11 25; 10(12).
    View in: PubMed
    Score: 0.770
  2. Production of endocannabinoids by activated T?cells and B?cells modulates inflammation associated with delayed-type hypersensitivity. Eur J Immunol. 2016 06; 46(6):1472-9.
    View in: PubMed
    Score: 0.527
  3. Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. Int Rev Immunol. 2015; 34(5):403-14.
    View in: PubMed
    Score: 0.459
  4. Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. PLoS One. 2014; 9(4):e93954.
    View in: PubMed
    Score: 0.453
  5. Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. J Leukoc Biol. 2014 Apr; 95(4):609-19.
    View in: PubMed
    Score: 0.443
  6. Endocannabinoids and immune regulation. Pharmacol Res. 2009 Aug; 60(2):85-92.
    View in: PubMed
    Score: 0.080
  7. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008 Jul; 74(1):20-33.
    View in: PubMed
    Score: 0.019
  8. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol. 2004 Aug 15; 173(4):2373-82.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.